Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma.
Saved in:
| Title: | Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma. |
|---|---|
| Authors: | Hájek R; University Hospital Ostrava & Faculty of Medicine, University of Ostrava, Ostrava, 703 00, Czech Republic., Minařík J; Palacky University & University Hospital Olomouc, Olomouc, 771 47, Czech Republic., Straub J; General Teaching Hospital, Prague, 128 08, Czech Republic., Pour L; University Hospital, Brno, 625 00, Czech Republic., Jungova A; Faculty Hospital Pilsen, Pilsen, 301 00, Czech Republic., Berdeja JG; Sarah Cannon Research Institute, Nashville, TN 37203, USA., Boccadoro M; University of Torino, Torino, 10124, Italy., Brozova L; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic., Spencer A; Alfred Health-Monash University, Melbourne, 3004, Australia., van Rhee F; University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA., Vela-Ojeda J; UMAE Especialidades Centro Medico La Raza IMSS, Ciudad de México, 02990, Mexico., Thompson MA; Advocate Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI 53227, USA., Abonour R; Indiana University School of Medicine, Indianapolis, IN 46202, USA., Chari A; Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Cook G; Leeds Teaching Hospital, Leeds, LS1 3EX, UK., Costello CL; Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA., Davies FE; Perlmutter Cancer Center, NYU Langone, New York, NY 10016, USA., Hungria VT; Clinica São Germano & Santa Casa Medical School, São Paulo, 04537-081, Brazil., Lee HC; M.D. Anderson Cancer Center, Houston, TX 77030, USA., Leleu X; Pôle Régional de Cancérologie, CHU de Poitiers, Poitiers, 86000, France., Puig N; Department of Hematology, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC (CB16/12/00233), Salamanca, 37007, Spain., Rifkin RM; Rocky Mountain Cancer Centers US Oncology Research, Denver, CO 80218, USA., Terpos E; National & Kapodistrian University of Athens, School of Medicine, Athens, 115 27, Greece., Usmani SZ; Levine Cancer Institute, Charlotte, NC 115 27, USA., Weisel KC; University Medical Center Hamburg-Eppendorf, Hamburg, 20251, Germany., Zonder JA; Barbara Ann Karmanos Cancer Institute / Wayne State University School of Medicine, Detroit, MI 48201, USA., Bařinová M; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic., Kuhn M; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic., Šilar J; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic., Čápková L; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic., Galvez K; Hospital Pablo Tobón Uribe, Medellin, 11001, Colombia., Lu J; Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Beijing, 100044, China., Elliott J; Millennium Pharmaceuticals, Inc., Cambridge, MA 02139, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Stull DM; Millennium Pharmaceuticals, Inc., Cambridge, MA 02139, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Ren K; Millennium Pharmaceuticals, Inc., Cambridge, MA 02139, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Maisnar V; Charles University Hospital & Faculty of Medicine, Hradec Králové, 121 08, Czech Republic. |
| Source: | Future oncology (London, England) [Future Oncol] 2021 Jul; Vol. 17 (19), pp. 2499-2512. Date of Electronic Publication: 2021 Mar 26. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33769076 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hájek+R%22">Hájek R</searchLink>; University Hospital Ostrava & Faculty of Medicine, University of Ostrava, Ostrava, 703 00, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Minařík+J%22">Minařík J</searchLink>; Palacky University & University Hospital Olomouc, Olomouc, 771 47, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Straub+J%22">Straub J</searchLink>; General Teaching Hospital, Prague, 128 08, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Pour+L%22">Pour L</searchLink>; University Hospital, Brno, 625 00, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Jungova+A%22">Jungova A</searchLink>; Faculty Hospital Pilsen, Pilsen, 301 00, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Berdeja+JG%22">Berdeja JG</searchLink>; Sarah Cannon Research Institute, Nashville, TN 37203, USA.<br /><searchLink fieldCode="AU" term="%22Boccadoro+M%22">Boccadoro M</searchLink>; University of Torino, Torino, 10124, Italy.<br /><searchLink fieldCode="AU" term="%22Brozova+L%22">Brozova L</searchLink>; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Spencer+A%22">Spencer A</searchLink>; Alfred Health-Monash University, Melbourne, 3004, Australia.<br /><searchLink fieldCode="AU" term="%22van+Rhee+F%22">van Rhee F</searchLink>; University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.<br /><searchLink fieldCode="AU" term="%22Vela-Ojeda+J%22">Vela-Ojeda J</searchLink>; UMAE Especialidades Centro Medico La Raza IMSS, Ciudad de México, 02990, Mexico.<br /><searchLink fieldCode="AU" term="%22Thompson+MA%22">Thompson MA</searchLink>; Advocate Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI 53227, USA.<br /><searchLink fieldCode="AU" term="%22Abonour+R%22">Abonour R</searchLink>; Indiana University School of Medicine, Indianapolis, IN 46202, USA.<br /><searchLink fieldCode="AU" term="%22Chari+A%22">Chari A</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.<br /><searchLink fieldCode="AU" term="%22Cook+G%22">Cook G</searchLink>; Leeds Teaching Hospital, Leeds, LS1 3EX, UK.<br /><searchLink fieldCode="AU" term="%22Costello+CL%22">Costello CL</searchLink>; Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA.<br /><searchLink fieldCode="AU" term="%22Davies+FE%22">Davies FE</searchLink>; Perlmutter Cancer Center, NYU Langone, New York, NY 10016, USA.<br /><searchLink fieldCode="AU" term="%22Hungria+VT%22">Hungria VT</searchLink>; Clinica São Germano & Santa Casa Medical School, São Paulo, 04537-081, Brazil.<br /><searchLink fieldCode="AU" term="%22Lee+HC%22">Lee HC</searchLink>; M.D. Anderson Cancer Center, Houston, TX 77030, USA.<br /><searchLink fieldCode="AU" term="%22Leleu+X%22">Leleu X</searchLink>; Pôle Régional de Cancérologie, CHU de Poitiers, Poitiers, 86000, France.<br /><searchLink fieldCode="AU" term="%22Puig+N%22">Puig N</searchLink>; Department of Hematology, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC (CB16/12/00233), Salamanca, 37007, Spain.<br /><searchLink fieldCode="AU" term="%22Rifkin+RM%22">Rifkin RM</searchLink>; Rocky Mountain Cancer Centers US Oncology Research, Denver, CO 80218, USA.<br /><searchLink fieldCode="AU" term="%22Terpos+E%22">Terpos E</searchLink>; National & Kapodistrian University of Athens, School of Medicine, Athens, 115 27, Greece.<br /><searchLink fieldCode="AU" term="%22Usmani+SZ%22">Usmani SZ</searchLink>; Levine Cancer Institute, Charlotte, NC 115 27, USA.<br /><searchLink fieldCode="AU" term="%22Weisel+KC%22">Weisel KC</searchLink>; University Medical Center Hamburg-Eppendorf, Hamburg, 20251, Germany.<br /><searchLink fieldCode="AU" term="%22Zonder+JA%22">Zonder JA</searchLink>; Barbara Ann Karmanos Cancer Institute / Wayne State University School of Medicine, Detroit, MI 48201, USA.<br /><searchLink fieldCode="AU" term="%22Bařinová+M%22">Bařinová M</searchLink>; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kuhn+M%22">Kuhn M</searchLink>; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Šilar+J%22">Šilar J</searchLink>; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Čápková+L%22">Čápková L</searchLink>; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Galvez+K%22">Galvez K</searchLink>; Hospital Pablo Tobón Uribe, Medellin, 11001, Colombia.<br /><searchLink fieldCode="AU" term="%22Lu+J%22">Lu J</searchLink>; Peking University People's Hospital, National Clinical Research Center for Hematologic Disease, Beijing, 100044, China.<br /><searchLink fieldCode="AU" term="%22Elliott+J%22">Elliott J</searchLink>; Millennium Pharmaceuticals, Inc., Cambridge, MA 02139, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.<br /><searchLink fieldCode="AU" term="%22Stull+DM%22">Stull DM</searchLink>; Millennium Pharmaceuticals, Inc., Cambridge, MA 02139, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.<br /><searchLink fieldCode="AU" term="%22Ren+K%22">Ren K</searchLink>; Millennium Pharmaceuticals, Inc., Cambridge, MA 02139, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.<br /><searchLink fieldCode="AU" term="%22Maisnar+V%22">Maisnar V</searchLink>; Charles University Hospital & Faculty of Medicine, Hradec Králové, 121 08, Czech Republic. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2021 Jul; Vol. 17 (19), pp. 2499-2512. <i>Date of Electronic Publication: </i>2021 Mar 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Observational Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33769076 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2217/fon-2020-1225 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2499 Titles: – TitleFull: Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hájek R – PersonEntity: Name: NameFull: Minařík J – PersonEntity: Name: NameFull: Straub J – PersonEntity: Name: NameFull: Pour L – PersonEntity: Name: NameFull: Jungova A – PersonEntity: Name: NameFull: Berdeja JG – PersonEntity: Name: NameFull: Boccadoro M – PersonEntity: Name: NameFull: Brozova L – PersonEntity: Name: NameFull: Spencer A – PersonEntity: Name: NameFull: van Rhee F – PersonEntity: Name: NameFull: Vela-Ojeda J – PersonEntity: Name: NameFull: Thompson MA – PersonEntity: Name: NameFull: Abonour R – PersonEntity: Name: NameFull: Chari A – PersonEntity: Name: NameFull: Cook G – PersonEntity: Name: NameFull: Costello CL – PersonEntity: Name: NameFull: Davies FE – PersonEntity: Name: NameFull: Hungria VT – PersonEntity: Name: NameFull: Lee HC – PersonEntity: Name: NameFull: Leleu X – PersonEntity: Name: NameFull: Puig N – PersonEntity: Name: NameFull: Rifkin RM – PersonEntity: Name: NameFull: Terpos E – PersonEntity: Name: NameFull: Usmani SZ – PersonEntity: Name: NameFull: Weisel KC – PersonEntity: Name: NameFull: Zonder JA – PersonEntity: Name: NameFull: Bařinová M – PersonEntity: Name: NameFull: Kuhn M – PersonEntity: Name: NameFull: Šilar J – PersonEntity: Name: NameFull: Čápková L – PersonEntity: Name: NameFull: Galvez K – PersonEntity: Name: NameFull: Lu J – PersonEntity: Name: NameFull: Elliott J – PersonEntity: Name: NameFull: Stull DM – PersonEntity: Name: NameFull: Ren K – PersonEntity: Name: NameFull: Maisnar V IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2021 Jul Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1744-8301 Numbering: – Type: volume Value: 17 – Type: issue Value: 19 Titles: – TitleFull: Future oncology (London, England) Type: main |
| ResultId | 1 |